SAN JOSE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Energous Corporation d/b/a Energous Wireless Power Solutions (NASDAQ: WATT) (the “Company”), a pioneer in scalable, over-the-air (OTA) wireless power networks, today announced financial results for the …
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”), a leader in the development of industrial-scale data centers, today announced its participation in several upcoming industry conferences. Cipher’s CEO …
Topline data readouts from multiple Phase 2 studies expected throughout 2025 VTX2735 in patients with recurrent pericarditis in H2 VTX3232 in participants with obesity and cardiometabolic risk factors in H2 VTX3232 biomarker study in patients with early …
Aleniglipron (GSBR-1290) ACCESS and ACCESS II studies fully enrolled; topline data from both studies anticipated by year-end 2025 Oral small molecule amylin receptor agonist (ACCG-2671) Investigational New Drug (IND)-enabling activities underway; First-in- …
Today, the Nebraska Department of Economic Development (DED) awarded $414,706 of matching funds for 16 talent recruitment proposals through the state’s Good Life Is Calling campaign. The agency received innovative proposals from a diversity of …
Full Year 2024 results US$25.6 billion Total Payment Volume, up 45% year-over-year Revenue of US$746 million, up 15% year-over-year 113% Net Revenue Retention Rate Gross Profit of US$295 million, up 6% year-over-year Adjusted EBITDA of US$189 million, down …
Reshaping its Board of Directors at the upcoming Shareholders’ meeting with the aim of enhancing U.S. outreach Preparations for PORTICO-2 Phase III trial with vafidemstat in agitation/aggression in Borderline Personality Disorder ongoing Final data …
PITTSBURGH, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Duolingo, Inc. (NASDAQ: DUOL) announced results for the fourth quarter and full year ended December 31, 2024 in a shareholder letter that is posted on its Investor Relations website at investors.duolingo.com. “ …
TORONTO and HAIFA, Israel, Feb. 27, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that it has been selected to present at MIXiii 2025, Israel’s premier Health Tech …
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the fourth quarter and full year 2024 on Monday, March 31, 2025, after market close. The …
Columbus, OH, Feb. 27, 2025 (GLOBE NEWSWIRE) -- This spring, Experience Columbus is inviting visitors to skip the crowds and experience a refreshingly unique spring break in Ohio's capital. Named a top 10 best big city in the U.S. and one of the best …
ROCKVILLE, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- On March 1, the American Kidney Fund (AKF) will kick off Kidney Month and shine a spotlight on kidney disease, a life-altering condition that impacts 1 in 7 American adults. Kidney Month provides an …
CLINTON, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Unity Bancorp, Inc. (NASDAQ: UNTY), parent company of Unity Bank, announced that its Board of Directors has declared a cash dividend of $0.14 per common share. Such dividend is payable on March 28, 2025, to …
BRONX, N.Y., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Local dignitaries, Ponce Bank officers and administrators, and members of the public will celebrate Ponce Bank’s transformed branch experience at the Grand Re-Opening, set for 12:30 pm, Thursday, February 27, …
Cash Generation of $34 million in Q4 after safe harbor equipment purchases, third consecutive quarter of positive Cash Generation Paid down $132 million of recourse debt in Q4 with excess cash Cash Generation guidance of $200 million to $500 million in …
Reports Quarterly Revenue of $298.4 Million, Reflecting 10.6% Growth Generated $52.2 Million of Quarterly Operating Cash Flow Issues Financial Guidance for 2025, Reflecting Tenth Consecutive Year of Revenue Growth NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) …
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that company management will participate in the following investor conferences: TD Cowen’s 45th Annual Healthcare Conference - March 3rd – …
Enrollment ongoing in Phase 3 barzolvolimab CSU studies; Phase 3 program in CIndU under development Phase 2 barzolvolimab EOE study fully accrued; Phase 2 study initiated in atopic dermatitis; enrollment ongoing in Phase 2 PN study Celldex’s first …
Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectations Achieves first full year of positive adjusted EBITDA as a public company, driven by operating leverage and strong medical benefits ratio …
Significant Demand for Amtagvi® (Lifileucel) Continues with Total Product Revenue of $73.7M in 4Q24 and $164.1M in FY24, Achieving Upper End of FY24 Guidance Range of $160M-$165M Reaffirming FY25 Total Product Revenue Guidance of $450M-$475M FY25 Cash Burn …
